Polomar Health ServicesPMHS 34 PS Ratio is 2.00 as of Jun. 30, 2026, which is 98% below its 10-year median of 131.65. GuruFocus rates PMHS with a GF Score™ of 34/100 and a GF Value™ of $12.34 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 58.3% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Polomar Health Services's share price is $0.118.
Polomar Health Services's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06. Hence, Polomar Health Services's PS Ratio for today is 2.00.
The historical rank and industry rank for Polomar Health Services's PS Ratio or its related term are showing as below:
PMHS'
s PS Ratio Range Over the Past 10 Years
Min: 1.22 Med: 131.65 Max: 1750
Current: 2
During the past 7 years, Polomar Health Services's highest PS Ratio was 1750.00. The lowest was 1.22. And the median was 131.65.
PMHS's PS Ratio is ranked worse than 58.3% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs PMHS: 2.00
During the past 7 years, Polomar Health Services's highest 3-Year average Revenue per Share Growth Rate was 184.40% per year. The lowest was 184.40% per year. And the median was 184.40% per year.
Back to Basics: PS Ratio
Polomar Health Services (OTCPK:PMHS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Polomar Health Services's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's PS Ratio distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Polomar Health Services's Share Price of today is $0.118. Polomar Health Services's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Polomar Health Services (PMHS) has a PS Ratio of 2.00 as of Jun. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Polomar Health Services and its competitors. This is 98% below median its historical median of 131.65. Over the past decade, Polomar Health Services' PS Ratio has ranged from 1.22 to 1,750.00. According to the industry distribution chart, Polomar Health Services ranks #383 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 58.3%.
Is Polomar Health Services' PS Ratio too high?
Polomar Health Services' current PS Ratio of 2.00 is 98% below median its 10-year median of 131.65. Over the past 10 years, this metric has ranged from a low of 1.22 to a high of 1,750.00. The Healthcare Providers & Services industry median PS Ratio is 1.50. Polomar Health Services' value of 2.00 is 33.3% above this industry median. Based on the distribution chart, Polomar Health Services ranks #383 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Polomar Health Services has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' PS Ratio compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #383 out of 657 companies for PS Ratio. This places Polomar Health Services in the lower half of its industry. The industry median PS Ratio is 1.50. Polomar Health Services' value of 2.00 is 33.3% above this benchmark. Historically, Polomar Health Services' own PS Ratio has ranged from 1.22 to 1,750.00 over the past decade. While the company's 10-year median is 131.65 vs. the industry median of 1.50, Polomar Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polomar Health Services's current PS Ratio of 2.00 is 33.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current PS Ratio is 2.00, which is 98% below median its own 10-year median of 131.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.34, compared to a current price of $0.12 — trading 99% below its estimated fair value. The current PS Ratio is 2.00, which is 98% below median its 10-year median of 131.65 and 33.3% above the Healthcare Providers & Services industry median of 1.50. Polomar Health Services' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current PS Ratio is 2.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polomar Health Services (PMHS) Overvalued in 2026?
Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued.
The current stock price of $0.12 is trading 99% below its estimated GF Value™ of $12.34.
GuruFocus considers Polomar Health Services to be Possible Value Trap.
Key valuation signals for PMHS:
PS Ratio: 2.00 (98% below median its 10-year median of 131.65)
GF Value™: $12.34 vs. price of $0.12 (99% below fair value)
Industry Position: 33.3% above the Healthcare Providers & Services median (#383 of 657)
No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
34GF Score
Get the complete analysis for PMHS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
